| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:e82.)
© 2003 American Heart Association, Inc.
Research Reports |
From the Centre de Résonance Magnétique Biologique et Médicale, UMR CNRS No. 6612, Faculté de Médecine de Marseille (F.N., Y.L., B.D., J.P.R., S.C-G., P.J.C.), and Unité neuro-vasculaire, Service de Neurologie, Hôpital Sainte-Marguerite (F.N., B.D.), Marseille, France.
Correspondence to P.J. Cozzone, PhD, Centre de Résonance Magnétique Biologique et Médicale, UMR CNRS No. 6612, Faculté de Médecine de Marseille, 27 Boulevard Jean Moulin, 13005 Marseille, France. E-mail patrick.cozzone{at}medecine.univ-mrs.fr
| Abstract |
|---|
|
|
|---|
Methods Six patients with hyperacute ischemic stroke were explored within the first 7 hours after onset with the use of a MR protocol including T2*-weighted MRI, DWI, SI, perfusion-weighted imaging, and MR angiography.
Results This study demonstrates, for the first time, a wide gradient of ischemia-related metabolic anomalies within the abnormal area delineated by DWI during hyperacute ischemic stroke. In the narrow range of decreased mean ADC values (0.60 to 0.40x10-9 m2 · s-1), a 33% decrease in mean ADC is associated with a 122% increase in lactate/N-acetyl aspartate ratio. Mean ADC values never fall below 0.40x10-9 m2 · s-1 within the severely affected ischemic tissue, while SI still detects a large metabolic heterogeneity inside areas showing similar decreased mean ADC values close to this threshold.
Conclusions Our results indicate that the region of very low mean ADC values observed during hyperacute ischemic stroke contains areas of various tissue damage intensity characterized by SI in relation to different stages of cellular metabolic injury. This observation may explain why ADC mapping does not reliably predict final infarct size.
Key Words: magnetic resonance imaging, diffusion-weighted spectroscopy, nuclear magnetic resonance stroke, acute
| Introduction |
|---|
|
|
|---|
See Editorial Comment, page e87
weighted imaging (DWI) may improve the prediction of stroke outcome compared with DWI alone. However, to our knowledge, the metabolic counterpart of ADC decrease is still undefined in patients with hyperacute ischemic stroke even though it may explain the failure of DWI to discriminate tissue at risk of infarction. To address this issue, we studied the relationship between ADC values and brain metabolic parameters measured by proton MR spectroscopic imaging (SI) during hyperacute ischemic stroke.
| Subjects and Methods |
|---|
|
|
|---|
MR exams were performed on a 1.5 T Siemens Vision Plus system. Isotropic ADC maps were reconstructed with the use of images acquired with a single-shot echo-planar imaging sequence (b=0, 500, 1000 s/mm2 applied in the x, y, and z directions; 19 slices; thickness=5 mm; matrix=128x128; field of view=256x256 mm2). Brain perfusion was assessed by bolus tracking. Sixty-five consecutive single-shot GE echo-planar imaging acquisitions were performed at a rate of 1 acquisition per second (echo time=60 ms; flip angle=60°; 7 slices; thickness=5 mm; matrix=128x128; field of view=256x256 mm2). Time to peak (TTP) and mean transit time (MTT) maps were calculated as described by Smith et al.7 Three consecutive diffusion MRI slices or perfusion MRI slices were averaged to match the regions explored by SI. Metabolic images were acquired by acquisition-weighted fast 2-dimensional spin-echo SI (echo time/repetition time=135 ms/1600 ms; slice thickness=15 mm; matrix 21x21; field of view=240x240 mm2; 454 acquisitions; water suppression performed during the acquisition with the VAPOR sequence8; 12-minute acquisition time9). These parameters resulted in an apparent nominal spatial resolution of 11x11 mm within a 15-mm-thick slice. However, in relation to the physical principles of the SI technique, the actual spatial resolution corresponded to elementary cylinders with a diameter of 22 mm and a height of 15 mm, resulting in a voxel volume of 5.7 mL, as explained in the report of Galanaud et al.9 This spatial resolution is close to that usually obtained by the single-voxel spectroscopy technique at 1.5 T: 8 mL (20x20x20 mm3) or 3.37 mL (15x15x15 mm3). None of the patients had lesions <5.7 mL in volume or 22 mm in dimension within a single 5-mm-thick ADC slice. The strict immobility of the patients head during SI acquisition was helped by the use of pads and pillows and was continuously monitored by a video system. Under these conditions, we did not observe any head movements in the cohort of 6 patients. The duration of the conventional MRI protocol was <10 minutes (T2*: 128 seconds; DWI: 48 seconds; PWI: 65 seconds; MRA: 40 seconds for intracranial arteries and 17 seconds for cervical arteries). The delay between the end of the DWI and the end of the SI was approximately 15 minutes.
Images from DWI and PWI parameters and metabolic images from SI were transformed in 256x256 matrix images with the use of a Fourier interpolation. This interpolation optimizes the informational content of spectroscopic images by increasing their apparent resolution via a 64% increase in measuring accuracy of the intensity and localization of MR signals registered during the SI acquisition.10,11 This Fourier interpolation allows a quantitative analysis of individual regions of interest (ROIs) centered on each pixel of the 256x256 matrix spectroscopic image, but the diameter of these ROIs cannot be <22 mm.9
The apparent distortion of metabolic map contours was related to the use of a mask corresponding to the skull signal and to outer volume saturation slices applied to eliminate the lipid signals from the scalp. Moreover, peripheral artifacts on metabolic maps caused by residual lipid contamination or magnetic field heterogeneity were also removed with the use of AMARES-MRUI FORTRAN code.12 After spatial realignment of images obtained by the various modalities, correlations between mean ADC values and metabolic ratios were measured in cylindric ROIs of 22 mm in diameter and 15 mm in thickness corresponding to the SI resolution before Fourier interpolation. These ROIs were defined inside the ipsilateral hypoperfused area delineated by MTT values equal or superior to the contralateral average MTT values +3 SDs and thus including the abnormal area delineated by the ADC map. The use of this rigorous statistical approach was possible owing to the low SD among the quasi-uniform MTT values measured in the parenchyma of the unaffected contralateral hemisphere. The coordinates of each ROI selected within the hypoperfused area were used to position the corresponding ROI of the averaged ADC map and of the spectroscopic image to perform appropriate correlations. The relationship between ADC values and metabolic parameters was not analyzed in anterior frontal regions owing to the presence of magnetic field inhomogeneities in these regions, which cause distortion artifacts in the echo-planar images and degrade the quality of spectroscopic images. Finally, 73 ROIs were defined in brain of patients with MCA occlusion (18, 17, 21, and 17 ROIs, respectively) (Figure 1) while, in relation to a smaller lesion, only 9 ROIs (1 and 8 ROIs, respectively) were defined in brain of the 2 patients without MCA occlusion. Data from SI (Figure 2) were expressed as the ratio of the resonance area of each detected metabolite over the sum of metabolites (S): N-acetyl aspartate (NAA), choline-containing compounds (Cho), and creatine-phosphocreatine (Cr). The use of metabolic ratios eliminates the bias related to a dilution effect caused by edema or cerebrospinal fluid contamination. Regression analysis between mean ADC values and metabolite ratios was performed with a linear or nonlinear regression model (Statview 5.0 software, Abacus Inc). The choice of the mathematical function performing the best-fit regression was based on the highest corresponding r value with a probability value <0.05. The use of this parametric statistical analysis was justified by the gaussian distribution of mean ADC values and metabolite ratios as demonstrated by a Kolmogorov-Smirnov test (probability values >0.1 indicated a gaussian distribution) (GraphPad InStat 3.0 software, GraphPad Software).
|
|
|
| Results |
|---|
|
|
|---|
|
|
| Discussion |
|---|
|
|
|---|
Whether or not the short 15-minute delay between the end of DWI acquisition and the end of SI acquisition in patients with MCA occlusion may be a confounder in our results is difficult to appreciate. Indeed, the duration of ischemia is one of the most important factors to consider when the reversibility of tissue injury is predicted. One can assume that a 15-minute delay is probably sufficient to observe significant changes in ADC values when DWI is performed during the first 2 hours of ischemia.15 However, this assumption probably does not hold beyond the initial 2-hour period because the decrease in ADC is then almost complete.16 This is the case in our patients who were explored between 3.5 and 7 hours after the onset of ischemia, when mean ADC had probably already reached its asymptotic lower values.14,15 Moreover, after the first 3 hours of ischemia, the short 15-minute delay is probably not sufficient to observe significant measurable changes in lactate and NAA signals owing to their respective kinetics of evolution, as analyzed in an experimental model of focal ischemia.15 Under these conditions, the delay between DWI and SI acquisitions is unlikely to be a significant confounder in our results.
The metabolic heterogeneity that we found in the ischemic area is probably related to different stages of tissue injury and metabolic dysfunction, ranging from an anaerobic glycolysis without detectable neuronal injury (isolated increase in lactate level) to a more severe metabolic degradation defined by an anaerobic glycolysis associated with a moderate or severe neuronal injury (combination of different levels of increase in lactate and decrease in NAA).15 The metabolic heterogeneity within the ischemic area is a well-known feature that has been related to the severity and the duration of hypoperfusion in human and animal studies.2,3,5,13 The slighter decrease in mean ADC value observed in the 2 patients without MCA occlusion but explored in the same time window as that for patients with MCA occlusion is in accordance with experimental studies that demonstrate moderately low ADC values inside the ischemic area after early reperfusion.13
The mismatch between diffusion and metabolic parameters brings novel insight to the understanding of the pathophysiology of ADC variations during hyperacute ischemic stroke, highlighting the added value of SI over DWI (Figures 3 to 5![]()
). As illustrated in Figure 1 (right part of curves), SI also discriminates between 2 metabolically distinct hypoperfused areas with subnormal to normal mean ADC and normal NAA/S level, modulated by the presence or the absence of lactate. The first hypoperfused area characterized by a subnormal to normal mean ADC value, a normal NAA/S level, and the presence of lactate matches well the diffusion-perfusion mismatch area (Figure 4), while the other hypoperfused area characterized by a subnormal to normal ADC mean value, a normal NAA/S level, and the absence of lactate (Lac/NAA=0) might possibly correspond to an oligemic zone. However, further studies with combined DWI and SI performed before and after early reperfusion using thrombolysis are needed to confirm this hypothesis. In addition, modern advances in SI techniques using an echo-planar sequence should soon provide fast 3-dimensional SI covering the entire brain in the same acquisition time as 2-dimensional SI.17 This new sequence might be of interest in the clinical assessment of acute ischemic stroke.
The present study demonstrates the potential of SI to evaluate early consequences of acute ischemia on brain cells and the existence of a gradient of cellular metabolic injury within the area of decreased mean ADC values. Interestingly, this metabolic gradient supports the idea that heterogeneity of ADC within infarcts5 is not only related to a difference in ADC reduction between gray and white matter18,19 but is also associated with a heterogeneity of the tissue metabolic injury, which in turn may explain why ADC is not a reliable predictor of final infarct size.
Although further studies of hyperacute ischemic stroke performed before and after thrombolysis are needed to definitely assess the prognostic value of SI, it is clear that brain evaluation by SI in ischemic patients provides a new metabolic dimension that is already presenting valuable information on the heterogeneity and gravity of lesions identified by DWI.
Received December 2, 2002; revision received February 28, 2003; accepted March 6, 2003.
| References |
|---|
|
|
|---|
2. Fiehler J, Foth M, Kucinski T, Knab R, von Bezold M, Weiller C, Zeumer H, Rother J. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke. 2002; 33: 7986.
3. Warach S. Tissue viability thresholds in acute stroke: the 4-factor model. Stroke. 2001; 32: 24602461.
4. Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab. 1998; 18: 583609.[CrossRef][Medline] [Order article via Infotrieve]
5. Fiehler J, Knab R, Reichenbach JR, Fitzek C, Weiller C, Rother J. Apparent diffusion coefficient decreases and magnetic resonance imaging perfusion parameters are associated in ischemic tissue of acute stroke patients. J Cereb Blood Flow Metab. 2001; 21: 577584.[Medline] [Order article via Infotrieve]
6. Parsons MW, Li T, Barber PA, Yang Q, Darby DG, Desmond PM, Gerraty RP, Tress BM, Davis SM. Combined 1H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome. Neurology. 2000; 55: 498505.
7. Smith AM, Grandin CB, Duprez T, Mataigne F, Cosnard G. Whole brain quantitative CBF, CBV, and MTT measurements using MRI bolus tracking: implementation and application to data acquired from hyperacute stroke patients. J Magn Reson Imaging. 2000; 12: 400410.[CrossRef][Medline] [Order article via Infotrieve]
8. Tkac I, Starcuk Z, Choi IY, Gruetter R. In vivo 1H NMR spectroscopy of rat brain at 1ms echo time. Magn Reson Med. 1999; 41: 649656.[CrossRef][Medline] [Order article via Infotrieve]
9. Galanaud D, Le Fur Y, Nicoli F, Denis B, Confort-Gouny S, Ranjeva JP, Viout P, Pelletier J, Cozzone PJ. Regional metabolite levels of the normal posterior fossa studied by proton chemical shift imaging. MAGMA. 2001; 13: 127133.[Medline] [Order article via Infotrieve]
10. Lindon JC, Ferrige AG. Digitisation and data processing in Fourier transform NMR. In: Emsley JW, Feeney J, Sutcliffe LH, eds. Progress in NMR Spectroscopy. Elmsford, NY: Pergamon Press; 1978: 2766.
11. Comisarow MB, Melka JD. Error estimates for finite zero-filling in Fourier transform spectrometry. Anal Chem. 1979; 51: 21982203.[CrossRef]
12. Vanhamme L, Van den Boogart A, Von Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson. 1997; 129: 3543.[CrossRef][Medline] [Order article via Infotrieve]
13. Hoehn-Berlage M. Diffusion-weighted NMR imaging: application to experimental focal cerebral ischemia. NMR Biomed. 1995; 8: 345358.[Medline] [Order article via Infotrieve]
14. Pierpaoli C, Alger JR, Righini A, Mattiello J, Dickerson R, Des Pres D, Barnett A, Di Chiro G. High temporal resolution diffusion MRI of global cerebral ischemia and reperfusion. J Cereb Blood Flow Metab. 1996; 16: 892905.[CrossRef][Medline] [Order article via Infotrieve]
15. Dreher W, Kühn B, Gyngell ML, Busch E, Niendorf T, Hossmann KA, Leibfritz D. Temporal and regional changes during focal ischemia in rat brain studied by proton spectroscopic imaging and quantitative diffusion NMR imaging. Magn Reson Med. 1998; 39: 878888.[Medline] [Order article via Infotrieve]
16. Kucinski T, Vaterlein O, Glauche V, Fiehler J, Klotz E, Koch C, Rother J, Zeumer H. Correlation of apparent diffusion coefficient and computed tomography density in acute ischemic stroke. Stroke. 2002; 33: 17861791.
17. Posse S, Dager SR, Richards TL, Yuan C, Ogg R, Artru AA, Muller-Gartner HW, Hayes C. In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: proton echo planar spectroscopic imaging (PEPSI). Magn Reson Med. 1997; 37: 858865.[Medline] [Order article via Infotrieve]
18. Kuroiwa T, Nagaoka T, Ueki M, Yamada I, Miyasaka N, Akimoto H. Different apparent diffusion coefficient: water content correlations of gray and white matter during early ischemia. Stroke. 1998; 29: 859865.
19. Mukherje P, McKinstry RC, Shimony JS, Akbudak E, Snyder AZ, Conturo TE, Bahn MM. Heterogeneity of apparent diffusion coefficients within infarcts. Stroke. 2001; 32: 16951696.
This article has been cited by other articles:
![]() |
S. Haik, D. Galanaud, M. G. Linguraru, K. Peoc'h, N. Privat, B. A. Faucheux, N. Ayache, J.-J. Hauw, D. Dormont, and J.-P. Brandel In Vivo Detection of Thalamic Gliosis: A Pathoradiologic Demonstration in Familial Fatal Insomnia Arch Neurol, April 1, 2008; 65(4): 545 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Leach, R. B. Fortuna, B. V. Jones, and M. F. Gaskill-Shipley Imaging of Cerebral Venous Thrombosis: Current Techniques, Spectrum of Findings, and Diagnostic Pitfalls RadioGraphics, October 1, 2006; 26(suppl_1): S19 - S41. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Guadagno, E. A. Warburton, P. S. Jones, D. J. Day, F. I. Aigbirhio, T. D. Fryer, S. Harding, C. J. Price, H. A. Green, O. Barret, et al. How affected is oxygen metabolism in DWI lesions?: A combined acute stroke PET-MR study. Neurology, September 12, 2006; 67(5): 824 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Feng, C. L. Dumoulin, S. Dashnaw, R. D. Darrow, R. L. DeLaPaz, P. L. Bishop, and J. Pile-Spellman Feasibility of Stent Placement in Carotid Arteries with Real-time MR Imaging Guidance in Pigs Radiology, February 1, 2005; 234(2): 558 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Kidwell, J. R. Alger, and J. L. Saver Evolving Paradigms in Neuroimaging of the Ischemic Penumbra Stroke, November 1, 2004; 35(11_suppl_1): 2662 - 2665. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |